Intermolecular (IMI) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
Intermolecular Reports Third Quarter and Nine Month 2018 Financial Results
November 6, 2018 4:15 PM ESTSAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ --Â Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for the third quarter and nine months ended September 30, 2018.
Q3 2018 Financial and Operational Highlights
Revenue of $7.9 million, which exceeded the company's guidance. Program revenue increased 7% year-over-year to $7.4 million. Adjusted EBITDA totaled $0.5 million, which exceeded the company's guidance and marked the company's fifth consecutive quarter of positive adjusted EBITDA. Net loss totaled $(0.7) million, an improvement from net loss of $(1.8)... More


